NCI's Research on COVID-19, Vaccines, and Antibodies - NCI

NCI's Research on COVID-19, Vaccines, and Antibodies - NCI

4.9
(258)
Write Review
More
$ 18.00
Add to Cart
In stock
Description

What are COVID-19 antibodies, is there a certain level needed for protection, and how well do COVID-19 vaccines work in people with cancer? In this Q&A, NCI experts discuss emerging research findings from the SeroNet program that are shedding light on these and other important questions.

Ohio State Researchers Cross Disciplines to Establish National STOP-COVID Center

Vaccines, Free Full-Text

Cancer Researchers Combat COVID-19, COVID and Cancer Report

Will cancer vaccines change the way we treat cancer?

Characterization of nanoparticles-based vaccines for COVID-19

Research Spotlight - Kaiser Permanente Division of Research

National Cancer Institute Thesaurus (NCIt)

COVID-19 and Cancer: a Comprehensive Review

mRNA vaccine-induced antibodies more effective than natural immunity in neutralizing SARS-CoV-2 and its high affinity variants

Antiviral drug discovery: preparing for the next pandemic - Chemical Society Reviews (RSC Publishing) DOI:10.1039/D0CS01118E

NCI's Research on COVID-19, Vaccines, and Antibodies - NCI

Antibodies and Vaccines as Drugs for COVID-19, keystone symposia

Antibodies and Vaccines as Drugs for COVID-19, keystone symposia